Compare
Orthopediatrics Corp vs Cerus Corp vs Lemaitre Vascular Inc vs Treace Medical Concepts, Inc.
| Latest fiscal year | Orthopediatrics Corp KIDS | Cerus Corp CERS | Lemaitre Vascular Inc LMAT | Treace Medical Concepts, Inc. TMCI |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $236.35M | $233.80M | $249.60M | $212.69M |
| Revenue growth (YoY) | +15.4% | +16.1% | +13.5% | +1.6% |
| Gross margin | 73.1% | n/a | 71.5% | 79.8% |
| Operating margin | -16.6% | -3.7% | 27.2% | -25.5% |
| Net margin | -16.8% | -6.7% | 23.1% | -27.7% |
| Net income | -$39.65M | -$15.63M | $57.73M | -$59.00M |
| EPS (Diluted) | -$1.69 | -$0.08 | $2.52 | -$0.93 |
| Operating cash flow | -$4.85M | $4.84M | $81.25M | -$15.97M |
| Free cash flow | -$15.96M | $1.11M | $74.47M | -$29.49M |
| Cash & equivalents | $19.56M | $19.96M | $28.24M | $10.71M |
| Total assets | $508.63M | $221.86M | $615.69M | $190.58M |
| Total liabilities | $162.03M | $156.89M | $222.17M | $103.25M |
| Shareholders' equity | $346.60M | $64.22M | $393.52M | $87.33M |
| Return on year-end equity | -11.4% | -24.3% | 14.7% | -67.6% |
| Shares outstanding | 25.09M | 192.14M | 22.77M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Orthopediatrics Corp | Cerus Corp | Lemaitre Vascular Inc | Treace Medical Concepts, Inc. |
|---|---|---|---|---|
| Latest | $236.35M Ended 2025-12-31 | $233.80M Ended 2025-12-31 | $249.60M Ended 2025-12-31 | $212.69M Ended 2025-12-31 |
| 1 year earlier | $204.73M Ended 2024-12-31 | $201.32M Ended 2024-12-31 | $219.86M Ended 2024-12-31 | $209.36M Ended 2024-12-31 |
| 2 years earlier | $148.73M Ended 2023-12-31 | $186.80M Ended 2023-12-31 | $193.48M Ended 2023-12-31 | $187.12M Ended 2023-12-31 |
| 3 years earlier | $122.29M Ended 2022-12-31 | $188.31M Ended 2022-12-31 | $161.65M Ended 2022-12-31 | $141.84M Ended 2022-12-31 |
| 4 years earlier | $98.05M Ended 2021-12-31 | $159.52M Ended 2021-12-31 | $154.42M Ended 2021-12-31 | $94.42M Ended 2021-12-31 |